Showing results (291-300 of 636) with videos related to

Sort By:
Pageof 64
Leukemia|May 23, 2001
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2S P Oomen, E G Lichtenauer-Kaligis, N Verplanke, et al.
The Netherlands Journal of Medicine|September 1, 1996
An unusual case of multiple endocrine neoplasia type 1 and the role of 111In-pentetreotide scintigraphyH H Ponssen, W W de Herder, H J Bonjer, et al.
Frontiers in Neuroendocrinology|January 1, 1993
Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphyS W Lamberts, L J Hofland, W W de Herder, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1991
Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian diseaseB C Fauser, T D Pache, S W Lamberts, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1992
Nasopharyngeal presentation of pituitary tumors. Differential diagnosis and treatmentA J van der Lely, P P Knegt, S Z Stefanko, et al.
European Journal of Endocrinology|December 1, 1994
Serum chromogranin A in the differential diagnosis of Cushing's syndromeF R Nobels, W W de Herder, D J Kwekkeboom, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growthJ W Koper, R Markstein, C Kohler, et al.
Hormone Research|January 1, 1987
Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after deliveryS W Lamberts, R Angement, A van der Heijden, et al.
Blood|October 1, 1993
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissueJ C Reubi, B Waser, U Horisberger, et al.
Clinical Endocrinology|October 1, 1995
IGFBP-3 is a poor parameter for assessment of clinical activity in acromegalyW W de Herder, A J van der Lely, J A Janssen, et al.
Pageof 64